Home › Plexiform Neurofibroma › Pennsylvania
Plexiform Neurofibroma clinical trials in Pennsylvania
4 studies for Plexiform Neurofibroma are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
- Children's Hospital of Philadelphia, Philadelphia
RecruitingObservational studyHealthy volunteers welcome
Ages 5 and older · All sexes · Updated Sep 22, 2026 · NCT02544022Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
- Children's Hospital of Philadelphia, Philadelphia
RecruitingPhase 1
Ages 16 and older · All sexes · Updated Aug 24, 2026 · NCT06502171A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
- Children's Hospital of Philadelphia, Philadelphia
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Jul 29, 2026 · NCT06541847Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
- Children's Hospital of Philadelphia, Philadelphia
RecruitingPhase 2
Ages 1 to 8 · All sexes · Updated May 29, 2026 · NCT06188741From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.